C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 7 890 JPY -0.25% Market Closed
Market Cap: ¥65.2B

Operating Margin

-190.8%
Current
Improving
by 996.5%
vs 3-y average of -1 187.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-190.8%
=
Operating Income
¥-686.9m
/
Revenue
¥360m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-190.8%
=
Operating Income
¥-686.9m
/
Revenue
¥360m

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Cuorips Inc
TSE:4894
64.9B JPY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 99% of companies in Japan
Percentile
1st
Based on 6 730 companies
1st percentile
-190.8%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Cuorips Inc
Glance View

Market Cap
65.2B JPY
Industry
Biotechnology

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Intrinsic Value
495.68 JPY
Overvaluation 94%
Intrinsic Value
Price
C
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-190.8%
=
Operating Income
¥-686.9m
/
Revenue
¥360m
What is Cuorips Inc's current Operating Margin?

The current Operating Margin for Cuorips Inc is -190.8%, which is above its 3-year median of -1 187.3%.

How has Operating Margin changed over time?

Over the last 1 years, Cuorips Inc’s Operating Margin has increased from -3 191.5% to -190.8%. During this period, it reached a low of -3 191.5% on Aug 30, 2024 and a high of -190.8% on Oct 30, 2025.

Back to Top